chrX-106802956-G-C
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_017752.3(TBC1D8B):c.103G>C(p.Gly35Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00001 in 1,095,810 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017752.3 missense
Scores
Clinical Significance
Conservation
Publications
- nephrotic syndrome, type 20Inheritance: XL Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D8B | ENST00000357242.10 | c.103G>C | p.Gly35Arg | missense_variant | Exon 1 of 21 | 1 | NM_017752.3 | ENSP00000349781.5 | ||
TBC1D8B | ENST00000310452.6 | c.103G>C | p.Gly35Arg | missense_variant | Exon 1 of 12 | 1 | ENSP00000310675.2 | |||
TBC1D8B | ENST00000481617.6 | c.103G>C | p.Gly35Arg | missense_variant | Exon 1 of 7 | 1 | ENSP00000421375.1 | |||
TBC1D8B | ENST00000276175.7 | c.103G>C | p.Gly35Arg | missense_variant | Exon 1 of 21 | 5 | ENSP00000276175.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD2 exomes AF: 0.0000505 AC: 9AN: 178380 AF XY: 0.0000471 show subpopulations
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1095810Hom.: 0 Cov.: 30 AF XY: 0.00000830 AC XY: 3AN XY: 361418 show subpopulations
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.103G>C (p.G35R) alteration is located in exon 1 (coding exon 1) of the TBC1D8B gene. This alteration results from a G to C substitution at nucleotide position 103, causing the glycine (G) at amino acid position 35 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at